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We describe neurobiological applications of RuBi-Glutamate, a novel caged-glutamate compound 
based on ruthenium photochemistry. RuBi-Glutamate can be excited with visible wavelengths 
and releases glutamate after one- or two-photon excitation. It has high quantum effi ciency and 
can be used at low concentrations, partly avoiding the blockade of GABAergic transmission 
present with other caged compounds. Two-photon uncaging of RuBi-Glutamate has a high spatial 
resolution and generates excitatory responses in individual dendritic spines with physiological 
kinetics. With laser beam multiplexing, two-photon RuBi-Glutamate uncaging can also be used 
to depolarize and fi re pyramidal neurons with single-cell resolution. RuBi-Glutamate therefore 
enables the photoactivation of neuronal dendrites and circuits with visible or two-photon light 
sources, achieving single cell, or even single spine, precision.
Keywords: uncaging, Ruthenium, bipyridine, RuBi-GABA
caged compounds, using ruthenium-bipyridine complexes (Zayat 
et al., 2003, 2005). Ruthenium is a transition metal, widely used due 
to its versatile chemistry. The polypyridines of ruthenium photore-
lease entire ligands in a heterolytic fashion, by means of a widely 
known mechanism in which the initial photoexcited state quickly 
evolves into a dissociative state, so the photorelease is therefore clean 
and fast (Zayat et al., 2003). We recently introduced a caged GABA 
compound (“RuBi-GABA”) that can be used for optical inactiva-
tion of neurons and functional mapping of GABAergic currents 
(Rial Verde et al., 2008). Now we describe the biological charac-
terization of a new caged glutamate compound, “RuBi-Glutamate”, 
which can be photoreleased with one- or two-photon excitation 
and has less nonspecifi c effects than MNI glutamate. The chemical 
synthesis and photochemical characterization of RuBi-Glutamate 
is described elsewhere (Salierno et al., submitted). Although we 
expect that RuBi-Glutamate will be useful for one-photon visible 
uncaging experiments, in this report we mainly focus in its use 
for two-photon photostimulation, since there are already several 
adequate choices available for neuronal photostimulation with one-
photon uncaging of glutamate (Callaway and Katz, 1993; Callaway 
and Yuste, 2002; Frick et al., 2001; Pettit et al., 1997; Shepherd et al., 
2003; Wieboldt et al., 1994; Yoshimura et al., 2005).
MATERIALS AND METHODS
SLICE PREPARATION AND ELECTROPHYSIOLOGY
350 µm thick coronal slices from 14-day-old C57BL/6 mouse 
cortex were prepared using a Leica VT1000-S vibratome with a 











. Slices were incubated at 
32°C in ACSF for 30 min and then kept at room temperature for 
at least 30 min before transferring them to the recording chamber. 
The recording chamber was bathed in ACSF (pH 7.4), also kept 
at room temperature and saturated with 95% O
2




Caged compounds are becoming widely used in neuroscience 
because they enable the optical manipulation of neuronal circuits 
(Hess, 1999). Using photoreleasable neurotransmitters such as 
glutamate and GABA, one can activate or inhibit neuronal proc-
esses, single neurons, or groups of neurons (Ellis-Davies, 2005). 
Combining this with functional imaging provides a near ideal 
method of monitoring and controlling neuronal activity, allowing 
an entirely optical method for analysis of neural circuits (Nikolenko 
et al., 2007).
In particular, two-photon uncaging of glutamate, with its excel-
lent spatial resolution, has been quite useful, due to the relatively 
high two-photon absorption cross sections of functionalized 
nitrobenzyl derivatives, such as 7-nitroindolinyl- and 4-methoxy-
7-nitroindolinyl-amino (MNI) glutamate (Canepari et al., 2001; 
Matsuzaki et al., 2001). For example, two-photon uncaging of 
MNI-glutamate has been used successfully to functionally map 
synaptic receptors (Matsuzaki et al., 2001), activate individual 
spines (Araya et al., 2006; Carter and Sabatini, 2004; Gasparini 
and Magee, 2006; Matsuzaki et al., 2004; Sobczyk et al., 2005) and 
activate individual neurons (Nikolenko et al., 2007). In spite of its 
utility, MNI- glutamate needs to be applied to the tissue at rela-
tively high (mM) concentrations for effective two-photon uncag-
ing. Unfortunately, at these concentrations, MNI-glutamate, like 
other caged compounds, is a very effective antagonist of GABAergic 
transmission (see below for MNI glutamate; Maier et al., 2005; 
Molnar and Nadler, 2000 for other compounds). This can be a 
signifi cant problem for its use in the study of neuronal circuits, as 
its application can lead to epileptiform events. Also, as it strongly 
blocks the GABAergic responses, it prevents the study of inhibitory 
network activity or connectivity.
To help circumvent this problem, we have exploited the fl exibil-
ity of ruthenium chemistry, and have synthesized a novel series of 
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, and 10 glucose.
Neurons were either held at their resting membrane potential 
(−65 mV), or at +40 mV, when both inhibitory and excitatory 
events were recorded. Whole-cell electrodes (4–7 MΩ) were used. 
To establish whole-cell access the cells were illuminated with an 
oblique light and an IR-pass fi lter on the microscope fi eld dia-
phragm, and visualized through a CCD camera (DAGE-MTI 
IR-1000) connected to a Sony PVM-137 black and white video 
monitor. All recordings, except those shown in Figures 2 and 3 
were performed with intracellular solution (pH 7.25), containing 
(in mM): 135 K-methylsulfate, 10 KCl, 10 HEPES, 5 NaCl, 2.5 Mg-
ATP, 0.3 Na-GTP, and 0.1 Alexa Fluor 594. Voltage-clamp recordings 
shown in Figures 2 and 3 were done with intracellular solution (pH 







-ATP, 0.4 Na-GTP, 10 Na
2
-phosphocreatine 
and 0.1 Alexa Fluor 594. Experiments were conducted at room 
temperature (22–25°C). We performed recordings from layer 2/3 
and 5 pyramidal cells using MultiClamp 700B (Molecular Devices) 
amplifi ers, and acquired the signals through a National Instruments 
PCI 6259 board using either custom software developed with 
LABView or Matlab. In a subset of experiments, electrical stimu-
lations were performed using a bipolar electrode placed in layer 
5. Repetitive stimuli were applied at a frequency of 0.2 Hz. CNQX 
(20 µM) and APV (40 µM) were routinely used while recording 
IPSCs, and TTX (2 µM) was added to the ACSF to isolate mini-
ature synaptic currents.
Off-line analysis was conducted using Matlab, MiniAnalysis 
v6.0.7 or IGOR Pro with the Neuromatic v2.0 package. For con-
sistency throughout the study, all measurements are expressed as 
mean ± SEM. Statistical signifi cance was assessed using Student’s 
t-test and the non-parametric Mann–Whitney test when appropri-
ate at the signifi cance level (p) indicated.
RuBi-GLUTAMATE UNCAGING
Images were acquired using a custom-made two-photon laser 
scanning microscope based on the Olympus FV-200 system 
(side-mounted to a BX50WI microscope with a 40× , 0.8NA, 
water immersion objective) and a Ti:sapphire laser (Chameleon 
Ultra II, Coherent, >3 W, 140 fs pulses, 80 MHz repetition rate). 
Fluorescence was detected with a photomultiplier tube (PMT: 
H7422-P40 Hamamatsu, Bridgewater, NJ, USA) connected to a sig-
nal amplifi er (Signal Recovery AMETEK Advanced Measurement 
Technology, Wokingham, UK) whose output was connected to the 
Fluoview system. First, images of the soma were acquired with 
Fluoview software (XY scan mode with 1× to 10× digital zoom), at 
850 nm using minimal power to prevent RuBi-Glutamate uncaging. 
As RuBi-Glutamate is light-sensitive, the computer screens and 
video monitor were covered with two layers of Rosco #27 medium 
red fi lters.
A somatic uncaging point was selected using custom software 
(Nikolenko et al., 2007), which triggered the uncaging pulse and 
controlled the pulse duration. Laser power was modulated by a 
Pockels cell (Quantum Technology, Lake Mary, FL, USA). For 
somatic stimulations, each uncaging target consisted of eight sub-
targets, each of which was illuminated for 8 ms, giving a total dura-
tion of ∼70 ms. The subtargets themselves were complex, consisting 
of fi ve very closely spaced beamlets created by multiplexing the laser 
beam with a diffractive optical element (DOE). The stimulations 
were repeated every 4 s. RuBi-Glutamate was added to the bath at 
300 µM concentration. The concentration chosen for two-photon 
experiments, 300 µM, was the lowest concentration with which 
we were able to fi re reliably using our stimulation protocol. While 
we performed other experiments with lower concentrations of 
RuBi-Glutamate (∼150 µM), neurons did not fi re consistently (or 
sometimes not at all). One-photon experiments, were performed 
with 30 µM the RuBi-Glutamate.
A Dynamax peristaltic pump (Ranin Instruments Inc., Woburn, 
MA, USA) was used to control bath perfusion to minimize total 
bath volume and re-circulate oxygenated media. Uncaging was 
performed with 800 nm light for two-photon experiments, and 
with 473 nm light for one-photon experiments.
To measure the lateral two-photon uncaging spatial resolution 
in single spines, the laser beam was positioned near the spine head 
(∼0.2 µm from the spine head edge) and subsequently moved away 
from the spine head edge. We specifi cally decided not to uncage 
glutamate directly over the spine head to avoid damaging the spine 
membrane, which we know can be harmed by direct laser illu-
mination. Instead, to prevent photodamage and trigger reliable 
glutamate responses without affecting the spine head, we directed 
the beam right next (∼0.2 µm) from the spine head edge. With this 
stimulus protocol, we can reliably photostimulate spines for long 
periods of time without any appreciable photodamage. In addition, 
to measure the axial resolution of the RuBi-Glutamate uncaging 
responses, the laser beam was positioned next to the spine head 
and the uncaging responses were recorded at different focal planes 
(spaced every 0.8 µm). In these tests, 4 ms laser pulses at 2 s interval 
were used. To record desynchronized spontaneous miniature excita-
tory post-synaptic potentials (mEPSPs) from layer 5 neurons, we 
replaced extracellular calcium with strontium (Xu-Friedman and 
Regehr, 2000). Comparisons between mini-PSPs (mPSPs) or mini-
PSCs (mPSCs) and photo-evoked responses are confounded by the 
spatial fi ltering. mPSPs or PSCs distributions are broad, stemming 
in part from the fact that the events are arising at many different 
spatial locations, each with a different cable-length fi ltering to the 
recording electrode, whereas in our photo-evoked responses the 
distances are much more uniform.
RESULTS












, with bpy = 
2,2′bipyridine and PMe
3
 = trimethylphosphine) is a caged gluta-
mate compound composed of a ruthenium center with six coordi-
nation positions, four of which are occupied by the two bidentate 
bipyiridines, the fi fth by a trimethylphosphine and the sixth by a 
molecule of L-glutamate, coordinated through its amino group 
(Figure 1A). Upon absorption of one photon of visible light, or 
two near infrared photons, RuBi-Glutamate photocleaves within 
nanoseconds, and releases glutamate from the Ru-bipyridine core, 
with a quantum yield of ∼0.13 at pH 7, and an extinction coeffi cient 
of >4,000 M−1 cm−1 at 473 nm (Salierno et al., submitted).
We fi rst examined the ability of RuBi-Glutamate to activate 
glutamate receptors by performing whole-cell recordings from 
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layer 2/3 pyramidal neurons in slices from mouse neocortex. Slices 
were bathed with a solution containing the caged form of RuBi-
Glutamate and the laser beam was aimed toward the somata of 
the recorded neurons, uncaging glutamate, while simultaneously 
recording the membrane potential from the activated neuron, 
and monitoring the effect of the uncaging. Using this functional 
assay to probe two-photon uncaging, we explored several dif-
ferent excitation wavelengths and concentrations and found 
800 nm to be optimal and 300 µM a suffi cient RuBi-Glutamate 
concentration to generate reliable functional responses. For the 
one-photon studies mentioned here, we used 473 nm light and 
30 µM RuBi-Glutamate, although because of the high absorption 
cross section for single photon excitation and the larger one-
 photon point spread function (PSF), we were also able to generate 
responses with concentrations as low as ∼5 µM (data not shown). 
These wavelengths and concentrations agree with those expected 
by examining the photochemical properties of RuBi-Glutamate 
(Salierno et al., submitted), and also match those previously used 
in our work with other members of that family of RuBi-caged 
compounds, such as RuBi-GABA (Rial Verde et al., 2008).
In pyramidal neurons, recorded under current clamp, two-
photon uncaging of glutamate generated brief depolarizations, 
but with a single laser spot, the evoked depolarizations were too 
small to reliably cause the cell to fi re action potentials. We there-
fore used a DOE to spatially multiplex the laser beam into fi ve 
closely spaced beamlets, a strategy that we have previously intro-
duced with MNI glutamate  photostimulation (Nikolenko et al., 
2007). This beamlet array was then directed onto eight subtargets 
on the cell (Figure 1B, upper panel), releasing more glutamate, 
generating stronger cellular responses leading to action potentials. 
Using this protocol, two-photon uncaging (on average, ∼70 ms, 
150–400 mW on the sample; n = 15 neurons) was able to reliably 
generate action potentials (Figure 1B, lower panel). Uncaging 
depolarizations ranged in amplitude from 1 to 20 mV and were 
effectively and reversibly blocked by bath application of the gluta-
mate receptor antagonists APV/CNQX (Figure 1C; 40/20 µM 
respectively; 96.7 ± 1.5% reduction in voltage, n = 6 neurons). In 
addition, in voltage-clamp conditions, RuBi-Glutamate uncaging 
generated inward currents that reversed at +10 mV, indicative of a 
glutamate receptor current (Figure 1D). These data confi rmed that 
FIGURE 1 | RuBi-Glutamate uncaging activates glutamate receptors. 
(A) Structure of Ruthenium-bipyridine-trimethylphosphine-Glutamate (RuBi-
Glutamate) and glutamate photorelease reaction. (B) Upper panel: Layer 2/3 
pyramidal cell loaded with Alexa-594 and position of the multiplexed uncaging 
laser targets (eight subtargets) on the soma of the cell. Lower panel: Action 
potentials triggered by uncaging of RuBi-Glutamate (300 µM) in a layer 2/3 
pyramidal neuron. In this example, one action potential was evoked with a 
power on sample of 180 mW and two with 220 mW. (C) RuBi-Glutamate 
activates glutamate receptors. Adding APV (40 µM) and CNQX (20 µM) blocked 
the uncaging response. (D) Representative current–voltage plot of uncaging 
responses. Note how it reverses at +10 mV, indicating that the responses are 
mediated by glutamate receptors.
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the uncaging of RuBi-Glutamate activated glutamate receptors in 
cortical pyramidal neurons.
EFFECT OF RuBi-GLUTAMATE ON SPONTANEOUS PSCs
We then characterized the pharmacological effect of RuBi-
Glutamate on synaptic receptors. As mentioned, the near complete 
blockade of inhibitory synaptic transmission by MNI-glutamate 
at concentrations useful for two-photon excitation (see below, 
Figure 3) prevents its clean use for circuit studies. To examine 
the effects from RuBi-Glutamate, we performed voltage-clamp 
recordings of spontaneous synaptic currents at different holding 
potentials, before and after bath application of RuBi-Glutamate. We 
performed these experiments with 300 µM, the same concentration 
of RuBi-Glutamate that we used for two-photon uncaging. We also 
carried out experiments in the presence and absence of the sodium 
channel blocker TTX, in order to specifi cally test whether mPSCs 
were specifi cally affected by RuBi-Glutamate.
At resting membrane potential of −65 mV, bath application 
of 300 µM RuBi-Glutamate had no detectable effect on the aver-
age amplitude, frequency or rise time of spontaneous PSCs or 
of mPSCs in the presence of TTX (Figure 2A, n = 1,562 events 
from six control neurons, 1,775 from six neurons in the presence 
of RuBi-Glutamate). Since at −65 mV most PSCs are excitatory, 
these data indicated that bath applied RuBi-Glutamate had no 
signifi cant effect on spontaneous excitatory PSCs (EPSCs). We 
then examined its potential effect on inhibitory PSCs (IPSCs), by 
performing similar experiments at +40 mV holding potential, a 
level at which both excitatory and inhibitory PSCs can be readily 
detected. At +40 mV, bath application of 300 µM RuBi-Glutamate 
produced a general trend of reducing the amplitude and frequency 
of spontaneous and miniature PSCs, with no apparent changes 
in the rise time of the events (Figure 2B). Although these effects 
were not statistically signifi cant, in the presence of TTX, we did 
observe a signifi cant reduction in PSCs frequency (p < 0.001, n = 6, 
t-test). This result, together with the lack of signifi cant effect at 
−65 mV, close to the reversal potential of IPSCs, indicated a poten-
tial antagonistic effect of the caged form of RuBi-Glutamate on 
inhibitory currents.
EFFECT OF RuBi-GLUTAMATE ON EVOKED INHIBITORY TRANSMISSION
To directly examine if RuBi-Glutamate had an antagonistic effect 
on IPSCs we conducted a series of experiments in which we evoked 
inhibitory currents by stimulating the neuropil surrounding the 
recorded neuron with a stimulating electrode, while holding the 
neuron at +40 mV, in the presence of APV and CNQX (40/20 µM, 
respectively) and thus better isolate IPSCs in the presence or 
absence of RuBi-Glutamate. The rationale of these experiments 
was to test whether RuBi-Glutamate blocked physiological synaptic 
GABAergic transmission, since our ultimate aim was to use two-
photon uncaging of RuBi-Glutamate for circuit studies. Side-by-
side experiments were performed with MNI-glutamate in order 
to examine its effect on GABAergic currents. We tested the effects 
from MNI-Glutamate at both 300 µM, the concentration used in 
our RuBi-Glutamate uncaging experiments, and at the higher con-
centrations of MNI-Glutamate needed (>2.5 mM), in our experi-
ence, for effective two-photon MNI-glutamate uncaging.
In these experiments, the perfusion of 300 µM RuBi-Glutamate 
generated a signifi cant reduction of the peak amplitude of the 
evoked GABAergic IPSCs (Figure 3: 50.0 ± 6.0%, n = 7 cells, 
p < 0.001). Perfusion of MNI-glutamate at the same concentrations 
(300 µM) generated an even more pronounced decrease in evoked 
IPSCs (Figure 3B; 83.0 ± 3.0%, n = 4, p < 0.001). At 2.5 mM, the 
concentration needed for effective two-photon uncaging, MNI-
glutamate completely blocked the evoked response (Figure 3: 
97.0 ± 2.0%, n = 6, p < 0.001).
We concluded that, although 300 µM RuBi-Glutamate has a 
signifi cant antagonist effect on endogenous GABAergic currents, 
this effect (close to 50%) is smaller compared with that of MNI 
glutamate (∼80% at 300 µM, ∼100% at the effective concentra-
tion of 2.5 mM). The differences between the 50% reduction 
observed in these RuBi-Glutamate experiments vs. the smaller 
reduction observed in the +40 mV recordings of spontaneous 
miniature potentials in TTX (Figure 2) may be partly due to 
the fact that at +40 mV one records a mixture of EPSCs and 
IPSCs.
RUBi-GLUTAMATE UNCAGING CAN ACTIVATE INDIVIDUAL DENDRITIC 
SPINES
We then tested the use of two-photon uncaging of RuBi-Glutamate 
for activating dendritic spines, one of the most useful applications 
of two-photon glutamate uncaging (Araya et al., 2006; Carter and 
Sabatini, 2004; Gasparini and Magee, 2006; Matsuzaki et al., 2004; 
Sobczyk et al., 2005). For these experiments, we performed whole-
cell recordings from pyramidal neurons and fi lled them with Alexa 
594 to optimally visualize their dendritic spines. We then bathed 
the slice in RuBi-Glutamate (300 µM) and directed a pulsed laser 
at the neuropil adjacent to a chosen spine (Figures 4A,B). With 
4 ms laser pulses, we triggered reliable depolarizations in the neu-
ron (see traces in Figures 4C,D). These responses were similar in 
amplitude to events recorded after two-photon uncaging of MNI-
glutamate (see Table 1). However, the RuBi-Glutamate generated 
neuronal responses had a rate of rise nearly twice as fast as those 
generated from uncaging MNI-glutamate (p < 0.001, n = 65 RuBi-
Glutamate uncaging events from four spines vs. n = 127 MNI-gluta-
mate uncaging events from nine spines). In addition, 10–90% rise 
times and 37% decay time kinetics were faster then those observed 
with uncaging of MNI-glutamate (p = 0.001 and p < 0.001, respec-
tively, Table 1), and more closely resemble the kinetics of sponta-
neous mEPSP (Table 1, see Materials and Methods for detection 
of mEPSPs).
In these single spine experiments, we also explored the spatial 
resolution of the uncaging responses, by monitoring the evoked 
depolarization while changing the position of the laser with 
respect to the dendritic spine. Moving the uncaging spot per-
pendicular to the spine (i.e., in the XY plane) resulted in a strong 
decrease in the amplitude of the uncaging response (∼80% reduc-
tion with the beam 1.3 µm away from the spine, Figure 4C; n = 7 
spines and 2 neurons). In the axial (Z) direction, a small change 
in position, 0.8 µm, also resulted in a strongly diminished voltage 
response (Figures 4D,E; 71% average reduction; n = 30 uncaging 
events, n = 2 neurons). These results are consistent with the small 
local uncaging volume defi ned by the two-photon PSF, and are 
similar to measurements obtained with two-photon uncaging of 
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MNI-glutamate (Araya et al., 2006). Thus, two-photon uncaging 
of RuBi-Glutamate has a spatial resolution that approximates 
the dimension of a typical dendritic spine, and therefore can be 
used to selectively activate individual spines.
RuBi-GLUTAMATE UNCAGING CAN ACTIVATE INDIVIDUAL NEURONS
Finally, we tested the potential use of RuBi-Glutamate for the optical 
photostimulation of neurons. These types of experiments, in which 
one uncages glutamate to elicit action potentials from a desired 
FIGURE 2 | Effect of RuBi-Glutamate on spontaneous synaptic currents. 
(A) Effects of RuBi-Glutamate on spontaneous activity recorded at a 
holding membrane potential of −65 mV. At this resting potential, RuBi-
Glutamate (300 µM) had no signifi cant effect on the average amplitude, 
frequency or rise time of spontaneous PSCs (n = 6 neurons) or of 
miniature PSCs recorded in the presence of TTX (n = 6 neurons). 
(B) Effects of RuBi-Glutamate on spontaneous activity recorded at +40 mV. 
RuBi-Glutamate (300 µM) tends to reduce the amplitude and frequency of 
spontaneous and miniature PSCs, but only the reduction of frequency 
of miniature PSCs is statistically signifi cant (p < 0.001, n = 6 neurons). 
There was no change in the rise time of the events. Because both 
excitatory and inhibitory events are recorded at +40 mV, this indicates 
that RuBi-Glutamate may have an inhibitory effect on IPSCs. Error bars 
represent SEM. ***p < 0.001.
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FIGURE 4 | Use of RuBi-Glutamate uncaging to optically activate dendritic 
spines. (A) Layer 2/3 neuron loaded with Alexa-594 to detect dendritic 
spines. (B) Higher resolution image of a dendritic spine selected for uncaging. 
Red dots indicate the sites of uncaging. (C) Plot of the XY spatial resolution 
of uncaging from the spine shown in (B) (Inset, traces corresponded to 
averages of 15 uncaging potentials at the different locations [1–4; red dots 
in (B)]. (D) Spatial axial resolution of uncaging. Z-stack of images from 
the stimulated spine. Traces corresponded to averages of 15 
uncaging potentials of its corresponding image stack. Red dots 
indicate the site of laser beam parking, not the actual size of the beam 
profi le. (E) Plot of the axial  resolution at the three different locations 
showed in (D).
FIGURE 3 | Effect of RuBi-Glutamate and MNI-glutamate on inhibitory 
transmission. (A) Voltage-clamp responses of a pyramidal neuron to 
extracellular electrical stimulation. An external bipolar stimulation electrode was 
used to evoke responses while clamping the neuron at +40 mV and in presence 
of APV (40 µM) and CNQX (20 µM) in the ACSF to isolate the GABA currents. 
Here we show examples of IPSCs evoked in control conditions, and the 
diminution of their amplitude after adding either RuBi-Glutamate (300 µM, left 
part) or MNI-Glutamate (300 µM or 2.5 mM, right part) to the bath. (B) 
Histogram showing averages of the inhibition of GABA current in presence of 
RuBi-Glutamate or MNI-Glutamate. **p < 0.01, ***p < 0.001.
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 neuronal target, have been very useful for mapping the synaptic inputs 
in slices (Callaway and Katz, 1993; Shepherd et al., 2003; Yoshimura 
et al., 2005). Moreover, with two-photon excitation, these inputs maps 
can be built with single-cell precision (Nikolenko et al., 2007).
These experiments were performed by recording from pyrami-
dal neurons with whole-cell electrodes and directed the uncag-
ing laser onto the soma of the cells, in slices bathed with 300 µM 
RuBi-Glutamate (Figure 5A). As previously mentioned, we used 
eight subtargets and a DOE to spatially multiplex the laser beam 
(Figure 5B). With this protocol we reliably generated action poten-
tials in the recorded neuron (90.0 ± 2.6% action potential occur-
rence, ∼70 ms uncaging pulses, n = 11 cells; Figure 5).
We characterized the effective spatial resolution of our multispot 
uncaging protocol by moving the spatiotemporally multiplexed 
FIGURE 5 | Use of RuBi-Glutamate uncaging to optically activate neurons. 
(A) Layer 2/3 pyramidal cells were fi lled with Alexa-594. (B) Position of the 
uncaging targets (eight subtargets). When placed on the somata, the 
uncaging elicited an action potential. When the targets were moved away 
from the soma, uncaging elicits only subthreshold depolarizations, and 
no response was evoked 10 µm away. (C) Lateral (XY plane) and axial (Z plane) 
resolution of RuBi-Glutamate uncaging to elicit either supra- or subthreshold 
events. Note how subthreshold depolarizations were strongly reduced when 
targets were placed 10 µm away from the soma in X-axis and 30 µm away in 
Z-axis (upper panel). Uncaging did not elicit an action potential if targets were 
moved from the soma 2 µm away in X-axis and 5 µm away in Z-axis (lower 
panel).
Table 1 | Effect of RuBi-Glutamate on spontaneous synaptic currents. Pairwise comparisons between MNI-Glutamate vs. RuBi-Glutamate, MNI-
Glutamate vs. mEPSP and RuBi-Glutamate vs. mEPSPs were statistically signifi cant for all four variables with p < 0.001. Values expressed as mean ± SEM.
 Amplitude (mV) Rate of rise (mV/ms) 10–90% rise time (ms) Decay time (ms)
RuBi–Glu 1.20 ± 0.09 (n = 65) 0.092 ± 0.01 (n = 65) 13.98 ± 1.13 (n = 65) 23.11 ± 1.79 (n = 59)
MNI–Glu 0.92 ± 0.03 (n = 127) 0.04 ± 0.002 (n = 127) 19.08 ± 1.24 (n = 127) 53.43 ± 4.24 (n = 114)
Sr2+–mEPSPs 0.55 ± 0.006 (n = 1,317) 0.06 ± 0.001 (n = 1,316) 8.20 ± 0.09 (n = 1,316) 16.06 ± 0.21 (n = 1,217)
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laser pattern away from the somata of the cell (Figure 5B), and 
measuring the amplitude of subthreshold postsynaptic depolariza-
tions and the probability of suprathreshold events as a function of 
the distance of the closest target from the cell edge. For subthresh-
old events, in the XY plane, we measured a strong decrease in the 
amplitude of the uncaging response, with a minimal response at 
10 µm away from the soma (normalized amplitude: 0.10 ± 0.01, 
n = 8 neurons; Figure 5C). Movements in the Z plane resulted 
in a smaller modulation of the response amplitude (normal-
ized amplitude: 0.19 ± 0.02 at 30 µm, n = 5 neurons; Figure 5C). 
Because the multiple beamlets and target pattern are dispersed 
in space, the subthreshold event spatial resolution was under-
standably worse than that that is obtained with single laser spots 
(Figure 4). Nevertheless, for suprathreshold events, we observed a 
strong decrease of the occurrence of evoked action potentials as the 
uncaging targets were moved only 2 µm from the edge of the soma 
in XY plane (3.0 ± 2.8% of occurrence of an action potential, n = 7 
neurons) and 5 µm above the soma in Z plane (10.0 ± 7.6%, n = 4 
neurons; Figure 5C). In these experiments, we avoided uncag-
ing near any prominent dendritic processes. However, the same 
stimulation conditions used to generate an action potential while 
targeting the soma, only generate subthreshold responses when 
intentionally (or accidentally) targeting the dendrites.
We also explored the use of one-photon RuBi-Glutamate uncag-
ing in similar experiments, using 30 µM RuBi-Glutamate and a 
single laser spot, aimed at the center of the somata. With 1 ms laser 
pulses, one-photon RuBi-Glutamate uncaging generated reliable 
depolarizations in the cell. The spatial resolution of this response 
was different in the XY and Z planes, with minimal responses at 
15 (normalized amplitude: 0.14 ± 0.03, n = 4 neurons) and 40 µm 
(normalized amplitude: 0.20 ± 0.03, n = 3 neurons), respectively.
These experiments demonstrated that RuBi-Glutamate can be 
used, in both one- and two-photon mode, for reliable photostimu-
lation of neurons in brain slices. In particular, the spatial resolution 
of two-photon DOE uncaging appears adequate for studies with 
single-cell precision.
DISCUSSION
Here we introduce the use of RuBi-Glutamate as a novel chemi-
cal tool for the photoactivation of individual dendritic spines and 
cortical neurons in circuits. In the past, glutamate uncaging has 
been successfully used to map circuits with one-photon excitation 
(Bureau et al., 2004; Callaway and Katz, 1993; Shepherd et al., 2003; 
Yoshimura et al., 2005). The synthesis of MNI-glutamate (Canepari 
et al., 2001; Matsuzaki et al., 2001) enabled the two-photon pho-
toactivation of spines (Araya et al., 2006; Matsuzaki et al., 2004) and 
neurons (Nikolenko et al., 2007), although the unspecifi c effects of 
MNI-glutamate on synaptic receptors have prevented its use for 
two-photon studies of inhibitory circuits.
RuBi-Glutamate has a number of desirable properties, such 
as a relatively high absorption cross section in the visible (blue) 
and a high quantum effi ciency of uncaging (Salierno et al., sub-
mitted). This combination allows RuBi-Glutamate to be used at 
lower concentrations than MNI-glutamate, lessening the blockade 
of GABAergic responses. The ability of the RuBi-compounds to 
absorb and uncage with visible light, compared to other caged gluta-
mate compounds, which require UV excitation, is also signifi cant, as 
blue light has higher penetration and lower toxicity for living tissue. 
Although we have only performed a cursory exploration of the use of 
RuBi-Glutamate for one-photon uncaging, we should mention that 
it has some useful features that other users may fi nd it potentially 
interesting for one-photon experiments. Specifi cally, we have effec-
tively uncaged glutamate with visible light from a variety of sources 
including standard mercury/xenon lamps, LED sources, or even laser 
pointers and fl ashlights, something that makes the instrumentation 
needed for glutamate uncaging experiments quite accessible and 
inexpensive. Also inexpensive glass optics instead of UV-transparent 
quartz can be used for uncaging of RuBi-Glutamate.
Perhaps more importantly, the red-shifted single photon spec-
trum leads to a red-shifted two-photon uncaging peak (800 nm 
for RuBi-Glutamate vs. 725 with MNI-Glutamate). In addition to 
the deeper penetration into tissue, 800 nm is near the peak of the 
maximum power output for the Ti-Sapphire lasers commonly used 
for two-photon experiments, which means more power is available 
to uncage glutamate at multiple sites simultaneously, an important 
consideration for future experiments aimed at probing complex 
neural circuit dynamics (Nikolenko et al., 2008).
Our initial experience with RuBi-Glutamate has been positive and 
we report a number of advantages that could make it widely used. It is 
water-soluble and does not have any strong pharmacological effects at 
the concentrations explored for effective one- or two-photon uncag-
ing. Although at higher concentrations (300 µM) it signifi cantly 
reduces GABAergic responses, it does not block them, so it could 
allow for the mapping of inhibitory circuits, and the stimulation of 
dendritic spines in regimes where inhibition is still partly engaged, 
resulting in more physiological experiments. This, combined with 
the decreased phototoxicity and increased penetration depth of the 
longer wavelengths required for uncaging RuBi-Glutamate compared 
with the nitrobenzyl and nitroindolinyl glutamate derivatives, could 
make in vivo uncaging experiments feasible.
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